| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
10,780,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Renovacor is a newly organized blank check company Chardan Healthcare Acquisition 2 is a newly organized blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses. Co.'s focus target is on businesses operating in North America in the healthcare industry.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wong Roderick |
10% Owner |
– – • |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,000,803) |
0 |
|
- |
|
| Amusa Gbolahan |
Director |
– • – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(278,588) |
0 |
|
- |
|
| Grossman Jonas |
Director |
– • – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(394,657) |
0 |
|
- |
|
| Cook Magdalene |
Chief Executive Officer |
• • – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(669,356) |
0 |
|
- |
|
| Cook Magdalene |
Chief Executive Officer |
• • – |
2022-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
147,083 |
147,083 |
|
- |
|
| Killeen Matthew |
Chief Scientific Officer |
• – – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,275) |
0 |
|
- |
|
| Dicicco Wendy F |
Chief Financial Officer |
• – – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(23,129) |
0 |
|
- |
|
| Dicicco Wendy F |
Chief Financial Officer |
• – – |
2022-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,329 |
4,329 |
|
- |
|
| Semigran Marc |
Chief Medical Officer |
• – – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(52,651) |
0 |
|
- |
|
| Semigran Marc |
Chief Medical Officer |
• – – |
2022-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,226 |
35,226 |
|
- |
|
| Benz Edward J. Jr |
Director |
– • – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,586) |
0 |
|
- |
|
| Benz Edward J. Jr |
Director |
– • – |
2022-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,586 |
3,586 |
|
- |
|
| Carroll Joseph S |
Chief Accounting Officer |
• – – |
2022-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,195) |
0 |
|
- |
|
| Carroll Joseph S |
Chief Accounting OfficerOffice |
• – – |
2022-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,195 |
|
- |
|
| Dicicco Wendy F |
Chief Financial OfficerOfficer |
• – – |
2022-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
23,129 |
|
- |
|
| Amusa Gbolahan |
Director |
– • – |
2022-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
238,588 |
278,588 |
|
- |
|
| Grossman Jonas |
Director |
– • – |
2022-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
354,657 |
394,657 |
|
- |
|
| Grossman Jonas |
Director |
– • – |
2022-04-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,605,661) |
0 |
|
- |
|
| Amusa Gbolahan |
Director |
– • – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
| Grossman Jonas |
Director |
– • – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
| Dicicco Wendy F |
Interim CFO |
• – – |
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,800 |
23,129 |
|
- |
|
| Killeen Matthew |
Chief Scientific Officer |
• – – |
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,275 |
5,275 |
|
- |
|
| Semigran Marc |
Chief Medical Officer |
• – – |
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
17,425 |
52,651 |
|
- |
|
| Cook Magdalene |
Chief Executive Officer |
• • – |
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
70,825 |
522,273 |
|
- |
|
| Wong Roderick |
10% Owner |
– – • |
2022-01-18 |
4 |
B |
$8.00 |
$355,520 |
I/I |
44,440 |
3,000,803 |
1.5 |
- |
|
61 Records found
|
|
Page 1 of 3 |
|
|
